Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects

Kidney International

Volumn 65, Issue 1, 2004, Pages 259-265

  Bosma, Renate J ^a   Homan Van Der Heide, Jaap J ^a   Oosterop, Eric J ^a   De Jong, Paul E ^a   Navis, Gerjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Body mass index; Obesity; Renal function; Renal hemodynamics; Renal risk

Indexed keywords

IODOHIPPURIC ACID; IOTALAMIC ACID;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BODY SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SEX RATIO;

EID: 0347992782     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00351.x     Document Type: Article

References (48)

1. PRAGA M, HERNANDEZ E, HERRERO JC, et al: Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58:2111-2118, 2000
2. BONNET F, DEPRELE C, SASSOLAS A, et al: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37:720-727, 2001
3. DRAFTS HH, ANJUM MR, WYNN JJ, et al: The impact of pretransplant obesity on renal transplant outcomes. Clin Transplant 11:493-496, 1997
4. MERION RM, TWORK AM, ROSENBERG L, et al: Obesity and renal transplantation. Surg Gynecol Obstet 172:367-376, 1991
5. MEIER-KRIESCHE HU, VAGHELA M, THAMBUGANIPALLE R, et al: The effect of body mass index on long-term renal allograft survival. Transplantation 68:1294-1297, 1999
6. MEIER-KRIESCHE HU, ARNDORFER JA, KAPLAN B: The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 73:70-74, 2002
7. HENEGAR JR, BIGLER SA, HENEGAR LK, et al: Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12:1211-1217, 2001
8. SCAGLIONE R, GANGUZZA A, CORRAO S, et al: Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord 19:403-409, 1995
9. RIBSTEIN J, DU CG, MIMRAN A: Combined renal effects of overweight and hypertension. Hypertension 26:610-615, 1995
10. REISIN E, MESSERLI FG, VENTURA HO, FROHLICH ED: Renal haemodynamic studies in obesity hypertension. J Hypertens 5:397-400, 1987
11. MESSERLI FH, CHRISTIE B, DECARVALHO JG, et al: Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med 141:81-85, 1981
12. TUCKER BJ, ANDERSON CM, THIES RS, et al: Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int 42:1160-1168, 1992
13. HALL JE: Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 23:381-394, 1994
14. ANASTASIO P, SPITALI L, FRANGIOSA A, et al: Glomerular filtration rate in severely overweight normotensive humans. Am J Kidney Dis 35:1144-1148, 2000
15. PORTER LE, HOLLENBERG NK: Obesity, salt intake, and renal perfusion in healthy humans. Hypertension 32:144-148, 1998
16. KAMBHAM N, MARKOWITZ GS, VALERI AM, et al: Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498-1509, 2001
17. VAN DER KLEIJ FG, DE JONG PE, HENNING RH, et al: Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake. J Am Soc Nephrol 13:1025-1033, 2002
18. VAN PAASSEN P, DE ZEEUW D, NAVIS G, DE JONG PE: Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension? Hypertension 27:202-208, 1996
19. APPERLOO AJ, DE ZEEUW D, DONKER AJ, DE JONG PE: Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol 7:567-572, 1996
20. DONKER AJ, VAN DER Hem, SLUITER WJ, et al: A radioisotope method for simultaneous determination of the glomerular filtration rate and effective renal plasma flow. Neth J Med 20:97-103, 1977
21. GARROW JS, WEBSTER J: Quetelet's index (W/H2) as a measure of fatness. Int J Obes 9:147-153, 1985
22. SALAZAR DE, CORCORAN GB: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 84:1053-1060, 1988
23. SCHMIEDER RE, BEIL AH, WEIHPRECHT H, MESSERLI FH: How should renal hemodynamic data be indexed in obesity? J Am Soc Nephrol 5:1709-1713, 1995
24. LINDEMAN RD, TOBIN J, SHOCK NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:278-285, 1985
25. FLISER D, FRANEK E, JOEST M, et al: Renal function in the elderly: Impact of hypertension and cardiac function. Kidney Int 51:1196-1204, 1997
26. FLEGAL KM, CARROLL MD, KUCZMARSKI RJ, JOHNSON CL: Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22:39-47, 1998
27. CHAGNAC A, WEINSTEIN T, KORZETS A, et al: Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 278:F817-F822, 2000
28. PINTO-SIETSMA SJ, NAVIS G, JANSSEN WM, et al: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41:733-741, 2003
29. HALL JE, BRANDS MW, HENEGAR JR, SHEK EW: Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol 25:58-64, 1998
30. YOUNG JB, LANDSBERG L: Diet-induced changes in sympathetic nervous system activity: Possible implications for obesity and hypertension. J Chronic Dis 35:879-886, 1982
31. HALL JE, BRANDS MW, DIXON WN, SMITH MJ, JR: Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension 22:292-299, 1993
32. SCHNERMANN J, WEIHPRECHT H, LORENZ JN, BRIGGS JP: The afferent arteriole - The target for macula densa-generated signals. Kidney Int 32(Suppl):S74-S77, 1991
33. TUCK ML, SOWERS J, DORNFELD L, et al: The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 304:930-933, 1981
34. DENGEL DR, GOLDBERG AP, MAYUGA RS, et al: Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 28:127-132, 1996
35. PRICE DA, LANSANG MC, OSEI SY, et al: Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabet Med 19:858-861, 2002
36. HALL JE, BRANDS MW, MIZELLE HL, et al: Chronic intrarenal hyperinsulinemia does not cause hypertension. Am J Physiol 260:F663-F669, 1991
37. TER MAATEN JC, BARKER SJ, SERNE EH, et al: Insulin's acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin's acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. Nephrol Dial Transplant 14:2357-2363, 1999
38. CONSIDINE RV, SINHA MK, HEIMAN ML, et al: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
39. WOLF G, CHEN S, HAN DC, ZIYADEH FN: Leptin and renal disease. Am J Kidney Dis 39:1-11, 2002
40. MADDOX DA, ALAVI FK, SANTELLA RN, ZAWADA ET, JR: Prevention of obesity-linked renal disease: age-dependent effects of dietary food restriction. Kidney Int 62:208-219, 2002
41. SARNAK MJ, POINDEXTER A, WANG SR, et al: Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 62:2208-2215, 2002
42. KASISKE BL, CLEARY MP, O'DONNELL MP, KEANE WF: Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 106:598-604, 1985
43. SCHMITZ PG, O'DONNELL MP, KASISKE BL, et al: Renal injury in obese Zucker rats: Glomerular hemodynamic alterations and effects of enalapril. Am J Physiol 263:F496-F502, 1992
44. ALONSO-GALICIA M, BRANDS MW, ZAPPE DH, HALL JE: Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 28:1047-1054, 1996
45. O'DONNELL MP, KASISKE BL, CLEARY MP, KEANE WF: Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. J Lab Clin Med 106:605-610, 1985
46. HAYASHI K, KANDA T, HOMMA K, et al: Altered renal microvascular response in Zucker obese rats. Metabolism 51:1553-1561, 2002
47. CARROLL JF, HUANG M, HESTER RL, et al: Hemodynamic alterations in hypertensive obese rabbits. Hypertension 26:465-470, 1995
48. NOEL PH, PUGH JA: Management of overweight and obese adults. BMJ 325:757-761, 2002